This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1997 Jan;10(1):142-3.

ALLHAT and calcium channel blockers. ALLHAT Research Group

M Proschan, B Davis, J Cutler, C Ford, C Furberg, R Grimm, S Oparil

PMID: 9008261

Comment

ALLHAT and calcium channel blockers. ALLHAT Research Group

M Proschan et al. Am J Hypertens. 1997 Jan.

. 1997 Jan;10(1):142-3.

Authors

M Proschan, B Davis, J Cutler, C Ford, C Furberg, R Grimm, S Oparil

PMID: 9008261

No abstract available

PubMed Disclaimer

Comment on

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.
Davis BR, Cutler JA, Gordon DJ, Furberg CD, Wright JT Jr, Cushman WC, Grimm RH, LaRosa J, Whelton PK, Perry HM, Alderman MH, Ford CE, Oparil S, Francis C, Proschan M, Pressel S, Black HR, Hawkins CM. Davis BR, et al. Am J Hypertens. 1996 Apr;9(4 Pt 1):342-60. doi: 10.1016/0895-7061(96)00037-4. Am J Hypertens. 1996. PMID: 8722437 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Medical
- ClinicalTrials.gov
- MedlinePlus Health Information